Tesamorelin: A Stabilised GHRH Analog in Endocrine Research

Tesamorelin is a stabilised analog of growth-hormone-releasing hormone (GHRH). Native GHRH is rapidly degraded by dipeptidyl peptidase enzymes; the analog carries a structural modification at the N-terminus that has been reported to slow that degradation, giving a longer-lived research tool for studying the same receptor. All activity described below is reported from in vitro and animal-model work.

The mechanism examined is engagement of the pituitary GHRH receptor, a G-protein-coupled receptor. In cell-based models the endpoints measured are intracellular cyclic AMP accumulation and growth hormone content in the medium of somatotroph preparations. Because the compound acts on the receptor rather than substituting for growth hormone, it is used as a probe of receptor pharmacology and of feedback within that axis in model systems.

In model systems, typical readouts include cAMP accumulation in pituitary cell preparations, growth hormone secretion profiles over time, and the pulsatility of that secretion compared with native GHRH.

Tesamorelin is used in endocrine research examining GHRH receptor pharmacology, somatotroph signalling and the regulation of the growth hormone axis.

It also appears in endocrine model systems where growth hormone axis markers are measured alongside lipid-handling assays in adipose tissue preparations; the recorded variables are analyte concentrations, not outcomes.

Regulatory note: tesamorelin is not authorised by the MHRA or the EMA for any use in the UK or EU, and no licensed pathway for it exists here. It is supplied strictly as a research-grade chemical for in vitro and preclinical laboratory work, is not supplied for any clinical purpose, and nothing on this page is clinical or medical information.

Tesamorelin is supplied as a lyophilised powder in a sealed amber vial. Lyophilised peptide material is generally most stable when the sealed vial is kept frozen and protected from light; condensation on cold glass is a known source of moisture ingress, which is why sealed vials are commonly equilibrated to ambient temperature before a seal is broken.

Handling of any laboratory chemical is determined by the receiving institution's own validated procedures, COSHH assessment and aseptic standards. This page carries no procedure, technique, diluent selection or preparation method; those fall outside its scope and are defined by the institution holding the material.

As a general point of peptide chemistry, solutions are less stable than dry material: degradation rates rise with temperature, light exposure and repeated freeze–thaw cycling. The stability window applicable to a given batch is stated on that batch's certificate of analysis. Batch number and receipt date recorded alongside experimental records keep results traceable to a specific batch.